QR-Code

Real-life cost-effectiveness of benralizumab in patients with severe asthma

Abstract Background Availability of clinically effective and cost-effective treatments for severe asthma would be beneficial to patients and national healthcare systems. The aim of this study was to evaluate clinical outcomes and healthcare expenditure after incorporating benralizumab into the stand...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: A. Padilla-Galo, A. J. García-Ruiz, R. Ch. Levy Abitbol, C. Olveira, F. Rivas-Ruiz, N. García-Agua Soler, M. Pérez Morales, B. Valencia Azcona, B. Tortajada-Goitia, I. Moya-Carmona, A. Levy-Naon
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2021-05-01
Schriftenreihe:Respiratory Research
Schlagworte:
Asthma
Benralizumab
Cost-effectiveness
Economic impact
Eosinophils
Biologics
Online-Zugang:https://doi.org/10.1186/s12931-021-01758-0
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge